摘要: To the Editor.— The article by Lipid Research Clinics Program 1 on reduction in instances of coronary artery disease was a very useful study for physician interested primary prevention disease. I have had relatively poor success keeping patients regimen cholestyramine my own practice because cost. least expensive form resin available through local pharmacy would cost patient $31.20 week to take 24 g/day. This comes total $1,622.40 year. If, as suggests, there are 1/2 million Americans who qualify this therapy, considerations become impressive. Some simple arithmetic demonstrates that nationwide each spared cardiac end point is $715,764.70. Who says surgery expensive?